 |
|
|
|
 |
|||
A lot of companies are jumping into M&A deals willingly, but that’s certainly not the case for Genzyme Corporation (GENZ), which is doing its best to fend off Sanofi-Aventis SA’s (SNY) $18.5 billion hostile takeover proposal – despite the buckets of cash that Genzyme’s executives would get in the process. On October 7, Genzyme issued a [...]
You can learn a lot by the way companies generally act when employees leave for another job, whether it’s with suspicion, enthusiasm or indifference. But what does it say when a company doesn’t just pay an executive to do something else — it keeps right on paying him? That’s what Aon Corp. (AON) did with [...]
The long weekend brought a bounty of riches to the footnoted table: some amusing, some intriguing, some just odd. Rather than focus on just one, we decided to take a quick spin through a few of the more unusual: Risky eating — The health-reform bill may prove better for your waistline than some restaurant bottom [...]
As the SEC deadline looms for large accelerated filers to file their 10-Ks by Monday, we’re reviewing literally hundreds of filings a day. Besides disclosing the state of their own debts, revenues, legal affairs (and so much more!), many companies are also discussing the state of the economy and what they think the future holds. [...]
As footnoted regulars know, SEC filings aren’t always that much fun. But this video, which I shot for CBS Moneywatch, tries to look at the lighter side of digging through filings. As an added plus, it shows how hard Kumara, the brain behind footnoted, really works.
